BiotechTube
Home/Pipeline/ARY-001

ARY-001

Solid Tumors

PreclinicalActive

Key Facts

Indication
Solid Tumors
Phase
Preclinical
Status
Active
Company
AryoGen Pharmed

About AryoGen Pharmed

Israeli biotech leveraging AI‑enhanced antibody engineering to create novel oncology and immunology therapeutics.

View full company profile

Therapeutic Areas

OncologyImmunology

Other Solid Tumors Drugs

DrugCompanyPhase
APVO603Aptevo TherapeuticsPreclinical
APVO711Aptevo TherapeuticsPreclinical
Platform-derived ImmunotherapyGenCirqPre-clinical
SP-2-225Shuttle PharmaceuticalsPreclinical
SP-1-161Shuttle PharmaceuticalsPreclinical
CAR-T Solid Tumor ProgramCarina BiotechPhase 1/2a
HBM1020Harbour BioMedPhase 1
HBM7022Harbour BioMedPhase 1
HBM9033Harbour BioMedDiscovery
Undisclosed Whole Cell Vaccine Program(s)NeuvogenPre-clinical
SY-5609Syros PharmaceuticalsPhase 1/2
Not Specified (TCR Therapy)T-Cure BiosciencePhase 1